ALKERMES | ALKS - Interest Income

Stock Price
33.31
Daily Change
-0.60 -1.77%
Monthly
13.42%
Yearly
19.65%
Q2 Forecast
32.32

ALKERMES reported $11.94M in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
AbbVie USD 72M 10M Sep/2025
Acadia Pharmaceuticals USD 8.25M 1M Sep/2025
ALKERMES USD 11.94M 853K Sep/2025
Biogen USD 31.6M 700K Sep/2025
BioMarin Pharmaceutical USD 17.85M 973K Sep/2025
Eli Lilly USD 65M 25M Sep/2025
Gilead Sciences USD 95M 7M Dec/2025
Heron Therapeutics USD 433K 277K Dec/2021
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
J&J USD 2.14 237M Mar/2026
Merck USD 96M 27M Sep/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Otsuka Holdings JPY 10.49B 396M Jun/2024
Pfizer USD 0.62 156M Sep/2025
Regeneron Pharmaceuticals USD 175.1M 300K Sep/2025
Vertex Pharmaceuticals USD 125.7M 3.3M Sep/2025